An auto-disable prefillable integrated package apparatus includes a first chamber, a second chamber, a connection configured to form a communicable channel between the first chamber and the second chamber, a frangible membrane configured to form a rupturable barrier within the connector that separates the first chamber and the second chamber, and a hub configured to be communicably coupled to the second chamber.

Provided are rapidly cross-linkable silicone compositions, systems, kits, and methods for filling implanted medical devices in situ, the implanted medical devices, including for example, body implants and tissue expanders, the compositions including a platinum divinyl disiloxane complex; a low viscosity vinyl terminated polydimethylsiloxane; a low viscosity hydride terminated polydimethylsiloxane; and a silicone cross-linker, where the rapidly cross-linkable silicone composition has a viscosity of ≤150 cPs for ≥1 min. post-preparation and ≤300 cPs≤5 min. post-preparation, at ambient temperature.

A pen includes a carpule having a longitudinal axis, a first end with a dispensing opening closable by a closure part, a second end via which at least one stopper can be inserted in the direction of the longitudinal axis, and an interior that is tightly closed by the closure part and the at least one stopper. A pen housing has a central axis, receives the carpule, and has a piston rod that interacts with the at least one stopper and a drive for moving the at least one stopper within the interior of the carpule, wherein the second end of the carpule can be inserted into the housing. The drive element moves the carpule into the housing in the direction of the longitudinal axis, which is arranged coaxially to the central axis of the housing, when the drive is activated; and in the process the piston rod is held in a fixed position with respect to the longitudinal direction of the housing such that the piston rod, which is engaged in the second end of the carpule, moves the at least one stopper within the interior of the carpule in the direction of the first end of the carpule.

Provided are rapidly cross-linkable silicone compositions, systems, kits, and methods for filling implanted medical devices in situ, the implanted medical devices, including for example, body implants and tissue expanders, the compositions including a platinum divinyl disiloxane complex; a low viscosity vinyl terminated polydimethylsiloxane; a low viscosity hydride terminated polydimethylsiloxane; and a silicone cross-linker, where the rapidly cross-linkable silicone composition has a viscosity of ≤150 cPs for ≥1 min. post-preparation and ≤300 cPs≤5 min. post-preparation, at ambient temperature.

Provided are rapidly cross-linkable silicone foam compositions, kits, and methods for filling implanted medical devices in situ or in vivo, the implanted medical devices, including for example, body implants and tissue expanders, the compositions including a platinum divinyl disiloxane complex; a low viscosity vinyl terminated polydimethylsiloxane; a low viscosity hydride terminated polydimethylsiloxane; a silicone cross-linker; and a gas and/or gas-filled microcapsules, where the rapidly cross-linkable silicone foam composition has a viscosity of ≤150 cPs for ≥1 min. post-preparation and ≤300 cPs≤5 min. post-preparation, at ambient temperature.

There is provided an applicator including: a first liquid flow path through which a first liquid containing fibrinogen passes; a second liquid flow path through which a second liquid containing thrombin passes; a confluence section in which the first liquid and the second liquid merge with each other to form a mixed liquid; and a gas flow path through which a gas for jetting the mixed liquid passes. At least part of a wall portion defining the confluence section is composed of a gas-permeable membrane that is impermeable to the mixed liquid and permeable to the gas.

In one aspect of the invention, a needle assembly is provided, including: a body having a proximal end, a distal end, and a channel located therebetween, the body being configured to be mounted to an injector; a needle fixed to the body, the needle having proximal and distal ends, the distal end extending distally from the distal end of the body and being formed for insertion into a patient, the proximal end of the needle being in communication with the channel; and, a filter disposed in the channel proximally of the proximal end of the needle. Advantageously, a needle assembly is provided which permits mixing of at least two substances in preparation for injection, without modification to the associated injector.

A telescoping syringe suitable for use with medications and other ejectable or injectable fluids is presented. The syringe includes a plunger, a barrel, and a valve. The plunger is extendible from and retractable into the barrel. The plunger defines a first reservoir. The barrel defines a second reservoir as the plunger is extended from the barrel. The valve is disposed at one end of the plunger adjacent to a nipple extending from the barrel. A first sealing interface is formed by the valve and a distal wall along the barrel adjacent to the nipple. A second sealing interface is formed by an annular flange along the one-way valve and an annular groove along the plunger. A third sealing interface is formed by the valve and a circumferential end along the plunger. The sealing interfaces are closed prior to extension of the plunger from the barrel thereby preventing a gas from entering and a fluid from existing the first reservoir. The sealing interfaces are open when the plunger is extended from the barrel so that the gas enters the first reservoir via an inlet(s) along the annular groove and fluid is communicated into the second reservoir via an outlet(s) along the valve. The second and third sealing interfaces are closed when the plunger is retracted into the barrel thereby allowing fluid to exit the second reservoir via the nipple.

Core annular flow is used to enable the subcutaneous delivery of a viscous fluid such as a protein therapeutic formulation. The high-viscosity fluid is surrounded by a low-viscosity fluid, and the low-viscosity fluid lubricates the passage of the high-viscosity fluid. This allows the use of protein formulations that have a higher concentration and a higher viscosity at comparatively reduced injection forces and reduced injection times. Several different embodiments of injection devices that provide core annular flow are described herein.

A telescoping portable drug mixing and delivery device configured to store a dry medication separately from a liquid component, wherein a tensile force applied between the housing and a cap opens a valve and causes displacement of a fluid from a first chamber to a second chamber while simultaneously mixing the fluid with a dry medicament prior to injection. An extendable needle guard is provided over the delivery assembly which prevents premature injection as well as inadvertent sticks or other cross contamination of a needle. The needle guard can also form part of a secondary trigger mechanism which injects the reconstituted drug after the mixing stage is complete.